
|Articles|April 21, 2008
Treximet, a sumatriptan and naproxen combination treatment, approved for migraine
GlaxoSmithKline gets FDA nod for combination migraine treatment
Advertisement
Acute migrane sufferers will now have a new option for treatment with a
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
3
Pharmacy Technology Should Focus on Patient Engagement, Peer Insight | NCPA 2025
4
Cardiovascular Disease Rates Increase for Patients With Mental Disorders During COVID-19 Pandemic
5